1-2 of 2
Christoph Huber, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotype, Function, and Safety of a p53 TCR Bicistronic GMP-Suitable Retroviral Construct.

Florian Rohrbach, PhD, Gunda Brandenburg, Ph.D., Edite Antunes Ferreira, Vera Wimmenauer, Daniel Hirsch, Thomas Stanislawski, Ph.D., Christoph Huber, M.D., Matthias Theobald, M.D.
Journal: Blood
Blood (2006) 108 (11): 3695.
https://doi.org/10.1182/blood.V108.11.3695.3695
Published: 2006
Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Wolfgang Kern, M.D., Hubert Serve, M.D., Peter Staib, M.D., Christa Kerschgens, M.D., Anett Matylis, M.D., Karin Tischmann, M.D., Christoph Huber, M.D., Wolf D. Hirschmann, M.D., Hartmut Eimermacher, M.D., Johann G. Lange, M.D., Anke Zumsprekerl, M.D., Georg Maschmeyer, M.D., Michael Unterhalt, M.D., Jörn Ohnesorge, Maria C. Sauerland, Wolfgang Berdel, M.D., Thomas Büchner, M.D., Torsten Haferlach, M.D., Claudia Schoch, M.D., Wolf D. Ludwig, M.D., Wolfgang Hiddemann, M.D.
Journal: Blood
Blood (2004) 104 (11): 871.
https://doi.org/10.1182/blood.V104.11.871.871
Published: 2004